Navigation Links
UBM Conferences Unveils Details for Upcoming Generics and Biosimilars Conference
Date:7/4/2012

AMSTERDAM, July 5, 2012 /PRNewswire/ -- Leading events organiser UBM Conferences, a division of UBM Plc (LSE: UBM), has announced details for its Generics and Biosimilars Conference to be held in Istanbul from September 18th to 20th at the Hilton Garden Inn Istanbul Golden Horn. The conference will focus on the advantages and challenges of operating in the evolving generics and biosimilars markets including: market potential; how to address pricing; legislative and regulatory hurdles; and the emergence of the EMEA regions including Central and Eastern Europe, the Commonwealth of Independent States (CIS), Turkey and the Middle East.

The three-day programme includes a full agenda of presentations, discussions and workshops that can be found here. Confirmed speakers for the Conference include high profile domestic and global representatives from companies like Merck, Sharpe and Dohme, Teva, Merck Bioventures, Pfizer, Biocad, Novartis, Mylan, Glenmark Generics and more, as well as support from the Bulgarian Generics Pharmaceutical Association, Jordanian Association of Pharmaceutical Manufacturers, the Russian Pharma Licensing Group and the Generics Bulletin.

"This year's event aims to facilitate networking and discussion between global and domestic players who are active in key pharmerging markets," stated Conference Producer, Joel Hornby.  "The Economist Intelligence Unit (EIU) forecasts five MENA markets will represent a combined GDP of US $2.5 trillion by 2016, led by Turkey and Saudi Arabia and the IHS Global Insight forecasts continued growth of about 10% in Russia. Now is the time to cultivate business relationships within this market, and the Generics and Biosimilars Conference offers an exceptional platform to do so."

Comprised of executives from business development, product development, sales and marketing, regulatory, scientific research
'/>"/>

SOURCE UBM Conferences
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. NYSE Companies and NASDAQ Companies June 7th Investor Presentations Now Available at RetailInvestorConferences.com
2. PDL BioPharma to Present at Upcoming Conferences
3. Sangamo BioSciences Announces Presentations At Upcoming Investor Conferences
4. CMC Biologics Highlights Technical Acumen at Upcoming Conferences
5. Halozyme Therapeutics to Present at Two Upcoming Investor Conferences in March
6. Organovo, Inc. Investor Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com
7. BioSpecifics Technologies Corp. Announces Presentations at Two Upcoming Investor Conferences in March
8. Organovo, Inc. to Webcast, Live, at RetailInvestorConferences.com on March 1st
9. Onyx Pharmaceuticals to Present at Upcoming Investor Conferences
10. Orexigen Therapeutics to Present at Upcoming Conferences
11. Ambit Biosciences to Present at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2, 2015 Amici Procurement Migrates ... company Amici Procurement has chosen Microsoft Cloud Solution Provider ... to Office 365.      (Logo: http://photos.prnewswire.com/prnh/20121126/579634) , ... medium-sized companies in the bio-tech sector with a unique ... purchasing cycle to help them obtain best value. Its ...
(Date:7/2/2015)... ... July 02, 2015 , ... In’Tech ... surgical instruments in Orthopedics, announced today the acquisition of Turner Medical, Inc ... provider of surgical instruments to the Spine Industry. The acquisition of Turner Medical ...
(Date:7/1/2015)... and PARIS , July 1, ... Genective, key developer of biotech crops, today announce ... new generations of insect control traits. ... counter the realities of advancing insect resistance. We ... unique insect control technology with Genective,s capability in ...
(Date:7/1/2015)... ... ... The next-generation sequencing (NGS) clinical market is poised for huge growth as it prepares ... in its new report that the market drivers of this vibrant industry include increased ... diagnostics as part of a molecular diagnostics trend. , The global market is forecast ...
Breaking Biology Technology:Biotech Procurement Company Moves to Office 365 with iomart 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3AgBiome and Genective collaborate to create novel insect-resistant crops 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 3
... ... Rolera MGi scientific camera is being launched into space today as part ... The Naval research Laboratory (NRL) chose the Rolera MGi because of its ... NASA will transmit the data to the NRL, which will then ...
... ... Research and Technology Platform for Life Sciences Marketing, R&D and Medical Affairs , ... Charlottesville, VA, San Diego, ... innovative tools for information and research for life sciences marketing, compliance, R&D and medical ...
... , CARLISLE, Pa., Sept. 9 ... food pathogen screening, today announced the issuance of a U.S. ... Infectious Microorganisms. The U.S. patent describes the Company,s method for ... nuts and other plant material intended for human and animal ...
Cached Biology Technology:First Spaceborne Hyperspectral Imager Will Use QImaging Rolera-MGi EMCCD Camera 2OpenQ Secures Investment from Leading Mid-Atlantic Venture Firm 2OpenQ Secures Investment from Leading Mid-Atlantic Venture Firm 3Hanson Technologies, Inc. Awarded Patent for its Advanced Food Pathogen Detection System 2
(Date:6/29/2015)... , June 24, 2015 ... of the "Latin America Biomedical Sensors Market - ... offering. The Latin America Biomedical Sensors market ... CAGR of 2.04% over the period 2014-2020 ... adaptable to the genetic formulation of each individual. These ...
(Date:6/24/2015)... 24, 2015 The biologics safety testing market ... for the market include growth of the pharmaceutical and ... launches. Over the years, the number of drug approvals ... 2010, the FDA approved 225 drug applications and Health ... Europe accounted for 3,822 of the ...
(Date:6/23/2015)... , June 23, 2015   MedNet Solutions ... supports the entire spectrum of clinical research, is ... ™ , the company,s intuitive, flexible and ... a Silver 2015 Stevie® Award by the ... & Services Website category.  The American Business Awards ...
Breaking Biology News(10 mins):Latin America Biomedical Sensors Market Report 2015-2020 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2
... more likely to be vaccinated against human papillomavirus (HPV) ... if they thought their mothers would approve of their ... May issue of Pediatrics (published online April ... and Norris Cotton Cancer Center, Megan Roberts, a PhD ...
... that a specific omega-6 fatty acid may be critical ... we knocked out a gene responsible for an enzyme ... arachidonic acid, the mice developed severe ulcerative dermatitis. The ... they developed a lot of bleeding sores," said Manabu ...
... 12, 2010 - Some patients with heart muscles seriously ... to benefit from an innovative treatment. Researchers at the ... Montral (CRCHUM), in collaboration with the Maisonneuve-Rosemont Hospital (MRH) ... stem cells into the hearts of patients while they ...
Cached Biology News:U of I study: Lack of omega-6 fatty acid linked to severe dermatitis 2How can you heal a broken heart? 2
Request Info...
... Kit Contains the following: , Coated Capture Antibody: ... , Wash/Sample Diluent: 300 mL of 2X concentrate ... 10 microg lyophilized peptide , Lyophilized Standard Diluent: ... 50X concentrate , Secondary Antibody-HRP: 30 microL of ...
carnitine deficiency-associated gene expressed in ventricle 1...
... Clone/PAD: ZMD.471. Immunogen: Synthetic peptide ... the mouse junctophilin-1. Specificity: Specific ... Mouse (positive controls: mouse brain and ... and skeletal muscle tissues). Applications: ...
Biology Products: